BCTX · IV Rank History

Briacell Therapeutics Corp. Common Shares

Embed BCTX IV rank

BCTX's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview

IV rank shows where BCTX's implied volatility sits within its own recent range: 0 is the lowest reading in the window, 100 the highest. This page gives the 52-week version, the 90-session version our screeners use, the IV percentile, and the daily history.

BCTX's 30-day at-the-money implied volatility was 384.1% as of Dec 31, 2024. Its 52-week IV rank is 74 and its IV percentile is 96%: IV was lower on 96% of the past year's sessions. Over those 52 weeks it ranged from 51.6% (Sep 18, 2023) to 501.0% (Oct 3, 2024). On the 90-session window our screeners use, the IV rank is 73.

BCTX IV rank history

230 sessions

Filled line: 90-session IV rank (0–100, left axis). Dashed line: 30-day at-the-money implied volatility (right axis).

BCTX IV rank and implied volatility as of 2024-12-31

52-Week IV Rank
74
0 = year low, 100 = year high
IV Percentile
96%
of past-year sessions had lower IV
90-Session IV Rank
73
used by our screeners
30-Day ATM IV
384.1%
1-year average 138.4%
7-Day ATM IV
454.7%
90-session rank 62
52-Week IV High
501.0%
2024-10-03
52-Week IV Low
51.6%
2023-09-18
History Since
2023-05-02
230 sessions

How these are measured. Implied volatility here is BCTX's 30-day at-the-money IV: the implied volatility of the calls and puts struck nearest the share price, blended between the expirations on either side of 30 days so every reading covers the same horizon. It's the IV level options traders usually quote, and it doesn't jump when the nearest expiration rolls from a weekly to a monthly. The 7-day figure is the same measure a week out, so it reacts first to near-term events such as earnings.

52-week IV rank = (today's IV − 52-week low) ÷ (52-week high − 52-week low) × 100. IV percentile is the share of the past year's sessions that closed with lower IV than today. The 90-session IV rank applies the same rank formula to the last 90 sessions, so it reacts faster.

A high reading means BCTX options are expensive relative to their own recent history, which is common ahead of earnings or after a sharp move. It says nothing about which way the stock will go. The Vol Arb Screener ranks every tracked symbol by these measures.

BCTX implied volatility by month

MonthAvg ATM IVHighLowAvg IV Rank (90-session)
Dec 2024 (to date) 345.0% 432.0% 253.7% 63
Nov 2024 440.3% 467.1% 413.6% 86
Oct 2024 290.3% 501.0% 167.4% 50
May 2024 172.5% 197.0% 148.1% 43
Apr 2024 193.8% 263.2% 125.4% 53
Mar 2024 199.4% 299.0% 144.9% 63
Feb 2024 146.1% 188.6% 104.6% 69
Jan 2024 137.0% 172.6% 112.1% 64
Dec 2023 116.6% 173.5% 75.6% 48
Nov 2023 114.0% 185.9% 97.7% 52
Oct 2023 97.3% 108.5% 76.8% 39
Sep 2023 84.0% 107.6% 51.6% 26
Aug 2023 92.4% 111.1% 79.6% 31
Jul 2023 106.0% 167.9% 72.3% 63
Jun 2023 84.8% 102.4% 71.5% 42
May 2023 77.4% 122.8% 57.8% 31

BCTX IV rank: last 30 sessions

DateIV Rank (90-session)30-Day ATM IV7-Day ATM IV
2024-12-31 73 384.1% 454.7%
2024-12-30 61 336.0% —
2024-12-20 42 253.7% —
2024-12-19 84 432.0% —
2024-12-18 42 255.1% —
2024-12-10 79 410.6% 277.1%
2024-12-09 46 269.8% 269.8%
2024-12-06 81 419.1% 244.2%
2024-11-29 79 413.6% —
2024-11-25 92 467.1% —
2024-10-28 30 203.2% —
2024-10-25 26 187.6% 187.6%
2024-10-24 39 239.9% —
2024-10-23 41 249.3% —
2024-10-22 27 189.7% —
2024-10-21 22 167.4% —
2024-10-17 26 185.2% —
2024-10-15 76 397.2% 675.0%
2024-10-11 66 356.1% —
2024-10-10 63 341.8% —
2024-10-09 65 353.4% —
2024-10-08 52 295.8% 646.0%
2024-10-07 33 215.4% —
2024-10-04 93 471.5% —
2024-10-03 100 501.0% 558.7%
2024-05-10 32 148.1% 148.1%
2024-05-09 54 197.0% 197.0%
2024-05-08 47 180.2% 180.2%
2024-05-07 46 178.8% 178.8%
2024-05-06 48 183.4% 183.4%

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.